EyePoint's Drug for Age-related Eye Disease Fails Late-stage Trial, Shares Tank

Published Date: 18 Aug 2026

EyePoint said its experimental drug missed the main goal in a late-stage trial as a few patients lost vision ⁠from causes unrelated to the targeted disease, sending its...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

NEJM: Pirtobrutinib is effective in CLL patients who have received prior BTK inhibitor therapy.

2.

The September 2018 issue of Medical Bulletin.

3.

10-year study shows tomosynthesis improves breast cancer detection

4.

Eltrombopag Improves Outcomes in Kids With Newly Diagnosed ITP

5.

Refractory Multiple Myeloma Responsive to Immunotherapy Plus Low-Dose Radiotherapy


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot